Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model

Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials

Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972

Roles of Pax-genes in developing and adult brain as suggested by expression patterns

Stoykova, A., & Gruss, P. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-03-01395.1994 · Cited by 577

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

Wang, J., Grundke, I., & Iqbal, K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05226.x · Cited by 569

Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo

Fulga, T. A., Elson-Schwab, I., Khurana, V., Steinhilb, M. L., Spires, T. L., Hyman, B. T., & Feany, M. B. (2007) · Nature Cell Biology · doi:10.1038/ncb1528 · Cited by 452

Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses

Mandelkow�, E. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.007 · Cited by 412

Complete Sequence of a Novel Protein Containing a Femtomolar‐Activity‐Dependent Neuroprotective Peptide

Bassan, M., Zamostiano, R., Davidson, A., Pinhasov, A., Giladi, E., Perl, O., Bassan, H., Blat, C., Gibney, G., Glazner, G. W., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721283.x · Cited by 394

The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation

Plattner, F., Angelo, M., & Giese, K. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603469200 · Cited by 340

New roles for astrocytes (stars at last)

Ransom, B. R., Behar, T. N., & Nedergaard, M. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.006 · Cited by 335

Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein

Zamostiano, R., Pinhasov, A., Gelber, E., Steingart, R. A., Seroussi, E., Giladi, E., Bassan, M., Wollman, Y., Eyre, H. J., Mulley, J. C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007416200 · Cited by 251

Activity-dependent neuroprotective protein: a novel gene essential for brain formation

Pinhasov, A., Mandel, S., Torchinsky, A., Giladi, E., Pittel, Z., Goldsweig, A. M., Servoss, S. J., Brenneman, D. E., & Gozes, I. (2003) · Developmental Brain Research · doi:10.1016/s0165-3806(03)00162-7 · Cited by 239

REVIEW: tau protein pathology in Alzheimer’s disease and related disorders

Tolnay, M., & Probst (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00182.x · Cited by 214

Neuronal injury and loss after traumatic brain injury: time course and regional variability

Sato, M., Chang, E. F., Igarashi, T., & Noble‐Haeusslein, L. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02905-5 · Cited by 202

Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency

Clodfelder‐Miller, B., Zmijewska, A. A., Johnson, G. V. W., & Jope, R. S. (2006) · Diabetes · doi:10.2337/db06-0485 · Cited by 187

Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis

Mandel, S., Rechavi, G., & Gozes, I. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.11.039 · Cited by 167

Regional distribution of Fluoro-Jade B staining in the hippocampus following traumatic brain injury

Anderson, K. J., Miller, K. M., Fugaccia, I., & Scheff, S. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.025 · Cited by 165

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

Matsuoka, Y., Gray, A. J., Hirata‐Fukae, C., Minami, S., Waterhouse, E. G., Mattson, M. P., LaFerla, F. M., Gozes, I., & Aisen, P. S. S. (2007) · Journal of Molecular Neuroscience · doi:10.1385/jmn/31:02:165 · Cited by 164

Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water Maze

Gozes, I., Giladi, E., Pinhasov, A., Bardea, A., & Brenneman, D. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39336-x · Cited by 157

Signature Tau Neuropathology in Gray and White Matter of Corticobasal Degeneration

Forman, M. S., Zhukareva, V. A., Bergeron, C., Chin, S. S., Grossman, M., Clark, C. M., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61154-6 · Cited by 149

NAP: Research and Development of a Peptide Derived from Activity-Dependent Neuroprotective Protein (ADNP)

Gozes, I., Morimoto, B. H., Tiong, J., Fox, A. W., Sutherland, K., Dangoor, D., Holser-Cochav, M., Vered, K., Newton, P. E., Aisen, P. S. S., et al. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00053.x · Cited by 144

Impaired Glutamate Transport in a Mouse Model of Tau Pathology in Astrocytes

Dabir, D. V., Robinson, M. B., Swanson, E., Zhang, B., Trojanowski, J. Q., Lee, V. M. ‐., & Forman, M. S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3861-05.2006 · Cited by 138

A Femtomolar Acting Octapeptide Interacts with Tubulin and Protects Astrocytes against Zinc Intoxication

Divinski, I., Mittelman, L. A., & Gozes, I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403197200 · Cited by 136

Multiple tubulin forms are expressed by a single neurone

Gozes, I., & Sweadner, K. J. (1981) · Nature · doi:10.1038/294477a0 · Cited by 130

Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process

Togo, T., & Dickson, D. W. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0569-x · Cited by 116

nNOS Expression in Reactive Astrocytes Correlates with Increased Cell Death Related DNA Damage in the Hippocampus and Entorhinal Cortex in Alzheimer's Disease

Šimić, G., Lucassen, P. J., Krsnik, Ž., Krušlin, B., Kostović, I., Winblad, B. G., & Bogdanović, N. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7448 · Cited by 116

Peptide neuroprotection through specific interaction with brain tubulin

Divinski, I., Holtser‐Cochav, M., Vulih, I., Steingart, R. A., & Gozes, I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03936.x · Cited by 108

Predictors of Conversion to Dementia of Probable Alzheimer Type in Patients with Mild Cognitive Impairment

Modrego, P. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506776383103 · Cited by 105

Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2.

Klupa, T., Malecki, M. T., Pezzolesi, M. G., Ji, L., Curtis, S., Langefeld, C. D., Rich, S. S., Warram, J. H., & Królewski, A. S. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2212 · Cited by 101

Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes

Furman, S., Steingart, R. A., Mandel, S., Hauser, J. M., Brenneman, D. E., & Gozes, I. (2004) · Neuron Glia Biology · doi:10.1017/s1740925x05000013 · Cited by 94

The peptide NAP promotes neuronal growth and differentiation through extracellular signal‐regulated protein kinase and Akt pathways, and protects neurons co‐cultured with astrocytes damaged by ethanol

Pascual, M., & Guerri, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04761.x · Cited by 93

Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze

Alcalay, R. N., Giladi, E., Pick, C. G., & Gozes, I. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.005 · Cited by 83

Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain

Veeranna, G. J., Shetty, K. T., Takahashi, M., Grant, P. G., & Pant, H. C. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00003-6 · Cited by 83

The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection

Gozes, I., & Divinski, I. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6s605 · Cited by 77

Activity-Dependent Neurotrophic Factor-9 and NAP Promote Neurite Outgrowth in Rat Hippocampal and Cortical Cultures

Smith‐Swintosky, V. L., Gozes, I., Brenneman, D. E., D’Andrea, M. R., & Plata‐Saláman, C. R. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:3:225 · Cited by 67

Multigene deletions on chromosome 20q13.13-q13.2 includingSALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay

Borozdin, W., Graham, J. M., Böhm, D., Bamshad, M. J., Spranger, S., Burke, L. W., Leipoldt, M., & Kohlhase, J. (2007) · Human Mutation · doi:10.1002/humu.9502 · Cited by 60

Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus

Furman, S., Hill, J. M., Vulih, I., Zaltzman, R., Hauser, J. M., Brenneman, D. E., & Gozes, I. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.077 · Cited by 59

Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome

Vink, J., Auth, J., Abebe, D. T., Brenneman, D. E., & Spong, C. Y. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.02.101 · Cited by 55

The Expression of Activity-Dependent Neuroprotective Protein (ADNP) is Regulated by Brain Damage and Treatment of Mice with the ADNP Derived Peptide, NAP, Reduces the Severity of Traumatic Head Injury

Gozes, I., Zaltzman, R., Hauser, J. M., Brenneman, D. E., Shohami, E., & Hill, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585873 · Cited by 53

Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress

Steingart, R. A., & Gozes, I. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.03.029 · Cited by 48

Brain Injury-Dependent Expression of Activity-Dependent Neuroprotective Protein

Zaltzman, R., Alexandrovich, A. G., Beni, S. M., Trembovler, V., Shohami, E., & Gozes, I. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:181 · Cited by 31

Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry

Hill, J. M., Hauser, J. M., Sheppard, L. M., Abebe, D. T., Spivak-Pohis, I., Kushnir, M., Deitch, I., & Gozes, I. (2007) · Journal of Molecular Neuroscience · doi:10.1385/jmn:31:03:185 · Cited by 31

Alzheimer Mechanisms and Therapeutic Strategies

Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758

The many faces of tau

Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899

A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP

Helsmoortel, C., Vulto-van Silfhout, A. T., Coe, B. P., Vandeweyer, G., Rooms, L., van den Ende, J., Schuurs-Hoeijmakers, J. H. M., Marcelis, C. L., Willemsen, M. H., Vissers, L. E. L. M., et al. (2014) · Nature Genetics · doi:10.1038/ng.2899 · Cited by 354

Autophagy has a key role in the pathophysiology of schizophrenia

Wagner, A. M., Malishkevich, A., Shemer, Z., Udawela, M., Gibbons, A. S., Scarr, E., Dean, B., Levine, J., Agam, G., & Gozes, I. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.174 · Cited by 239

Genetics and genomics of autism spectrum disorder: embracing complexity

De Rubeis, S., & Buxbaum, J. D. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv273 · Cited by 208

Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J Pharmacol Exp Ther. 2007; 323:438–49. [PubMed: 17720885

Vulih, I., Pinhasov, A., Shmuel, M., Grigoriadis, N., Touloumi, O., Pittel, Z., & Gozes, I. (2016)

P3‐428: Activity‐dependent neuroprotective protein (ADNP) is regulated in the brains of mouse models of human tauopathies: Toward davunetide replacement therapy

Gozes, I., Schirer, Y., & Oz, S. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1971 · Cited by 1

S4–04–03: Protecting the brain by nasal peptide delivery: From concept to the clinic

Gozes, I., Shiryaev, N., Jouroukhim, Y., Pinhasov, A., Ginzburg, I., & Rosenmann, H. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.286 · Cited by 1

P4–333: NAP reduces phosphorylated tau in AD transgenic mice

Matsuoka, Y., Gray, A. J., Li, H., Hirata‐Fukae, C., Planel, E., Duff, K., Mattson, M. P., Gozes, I., & Aisen, P. S. S. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.2074 · Cited by 1

NAP: Research and Development of a Peptide Derived from Activity-Dependent Neuroprotective Protein (ADNP)

Gozes, I., Morimoto, B. H., Tiong, J., Fox, A. W., Sutherland, K., Dangoor, D., Holser-Cochav, M., Vered, K., Newton, P. E., Aisen, P. S. S., et al. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00053.x · Cited by 144